RIVN director to sell 17,450 restricted shares

Robert J. Scaringe reported proposed sales of common stock.

Rhea-AI Filing Summary

Robert J. Scaringe reported proposed sales of common stock. The filing lists 17,450 shares of Restricted Common Stock to be sold on 11/15/2025. The form also records sales during the prior three months: 12/23/2025 17,450 shares for $373,871.49; 01/06/2026 17,450 shares for $341,072.47; 01/20/2026 17,450 shares for $279,763.64; 02/18/2026 34,900 shares for $586,236.24; and 03/03/2026 17,450 shares for $261,750.00.

Insights

Insider Transaction Analyst

Routine insider sale notice with recent dispositions recorded.

The filing documents a proposed sale of 17,450 restricted shares on 11/15/2025 and lists multiple open-market dispositions totaling visible shares across late 2025 and early 2026. The amounts for each recorded sale are shown in the excerpt.

These entries are procedural disclosures under Form 144. The filing itself does not state trading plan details or remaining post-transaction holdings; subsequent filings may provide additional position context.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did RIVN insider Robert J. Scaringe report on Form 144?

He reported a proposed sale of 17,450 restricted shares dated 11/15/2025. The filing also lists multiple recent sales between 12/23/2025 and 03/03/2026 with proceeds for each transaction shown in the excerpt.

How many shares did Robert J. Scaringe sell in February 2026 on RIVN-related filings?

The excerpt shows a sale of 34,900 Common shares on 02/18/2026 for $586,236.24. Other listed sales in the period are separate transactions on different dates with individual proceeds.

Does the Form 144 specify whether proceeds go to the issuer or the seller for RIVN?

The provided excerpt lists sale dates, share counts, and dollar amounts for each transaction. It does not state the cash-flow treatment or specify whether proceeds are paid to the issuer or the selling holder in the visible text.

Are the 17,450 shares to be sold by Scaringe registered or restricted for RIVN?

The filing labels the securities to be sold as Restricted Stock with a transaction date of 11/15/2025. The entry identifies the issuer context but does not include additional registration mechanics in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:18 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001891517
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RIVIAN AUTOMOTIVE, INC.
SEC File Number	001-41042
Address of Issuer	14600 MYFORD ROAD IRVINE CALIFORNIA 92606
Phone	(888) 748-4261
Name of Person for Whose Account the Securities are To Be Sold	ROBERT J. SCARINGE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17450	272230.47	1237077289	03/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/15/2025	Restricted Stock	ISSUER			17450	11/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT J. SCARINGE 14600 MYFORD ROAD IRVINE CA 92606	Common	03/03/2026	17450	261750.00
ROBERT J. SCARINGE 14600 MYFORD ROAD IRVINE CA 92606	Common	02/18/2026	34900	586236.24
ROBERT J. SCARINGE 14600 MYFORD ROAD IRVINE CA 92606	Common	01/20/2026	17450	279763.64
ROBERT J. SCARINGE 14600 MYFORD ROAD IRVINE CA 92606	Common	01/06/2026	17450	341072.47
ROBERT J. SCARINGE 14600 MYFORD ROAD IRVINE CA 92606	Common	12/23/2025	17450	373871.49

144: Remarks and Signature

Remarks
Date of Notice	03/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Joseph Scaringe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)